红日药业：当前管理团队结合行业政策环境变化及公司实际资源状况，制定了符合现阶段发展的研发战略

Group 1 - The core viewpoint of the article is that Hongri Pharmaceutical is adapting its R&D strategy in response to changes in industry policy and its own resource situation [2] Group 2 - The management team is actively engaging with investors to address their concerns and provide updates on the company's strategic direction [2] - The R&D strategy is aligned with the current stage of development for the company, indicating a proactive approach to industry dynamics [2]